课题基金 / 基金详情

Establishment of simulation model for human drug metabolism by bioartificial liver

Establishment of simulation model for human drug metabolism by bioartificial liver
生物人工肝人体药物代谢模拟模型的建立
批准号:
16590441
负责人:
NAGAO Takeshi
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2006

项目摘要

项目成果

NAGAO Takeshi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We have continued to study by using radial flow bio artificial liver. The expression of CYP3A4 was extremely increased after culturing liver cells in this system. We used FLC cells which originally expressed CYP3A4 and keep high function. After we cultured other liver cells that express CYP3A4 in RFB, CYP3A4 mRNA expressed much more than monolayer culture as well as FLC cells. Furthermore, we cultured GS3A4-HepG2 which introdued gene of glutamin synthetase and CYP3A4 in RFB. As a result, we determined that annmonium was metabolized effectively by those cells under RFB culture.Next, we investigated whether other several liver cell lines are suitable for RFB culture or not. We got the results that the cells which those doubling time were shorter than 24hr could culture on RFB. We speculated that the cells which doubling time was longer than 24hr might be thrown away before attaching on culture matrix. We presented these results at the Japanese congress of regeneration on 2005.On the othe … More r hand, we investigated the differences of expression of CYP1A1, 2D6, 2A6, 2C9, and 2C19 except for CYP3A4 after culturing on RFB or monolayer. As a result, we only got the differences of expression of 2D6 after culturing between them. We could not get the differences of 1A1, which means that enzyme associated with tumorgenesis did not induce.But, expression of arginosuccinate lyase, carbamoyl-p-synthetase, argininosuccinate synthetase that are uremic enzyme on those cell lines increased after RFB culture, and their production of alphafetoprotein (AFP) was inhibited.Furthermore, we also tried to culture kidney cells on RFB because we want to apply RFB for treatment of hepatocellular syndrome.Among them, proximal tubular cells (PTC) were capable of culture on RFB and their function also was increased. For example, expression of CYP27 was increased and expression extracellular matrix was increased on high glucose/hypoxic culture of PTC by using RFB. These results indicated that both high glucose and hypoxia might be necessary to induce acute renal failure. We presented these results at the congress of regeneration on 2005 and congress of Tokyo medical university on 2006, and Dr.Jojima got the grant from Tokyo medical university. Finally, we reported these results on Journal of Tokyo medical university on 2006. Less
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
ラジアルフロー型バイオリアクターを用いた糖尿病性腎障害病態の解析
使用径向流生物反应器分析糖尿病肾损伤病理学
DOI: --
发表时间: 2006
期刊: 東京医科大学雑誌 64(5)
影响因子: --
作者: [Munehide M, et al., Yamaori S et al., Lei Huang et al., 城島 嘉麿]
通讯作者: 城島 嘉麿
In vitro analytic model of diabetes mellitus glomerulonephropathy using a bioartificial column
使用生物人工柱的糖尿病肾小球肾病的体外分析模型
DOI: --
发表时间: 2006
期刊: Journal of Tokyo medical university vol64(5)
影响因子: --
作者: [Munehide M, et al., Yamaori S et al., Lei Huang et al., 城島 嘉麿, Ueda S., Saruwatari J et al., Yoshihiro Hotta et al., Y.Jojima]
通讯作者: Y.Jojima
Liver transplantation from non-heart-beating donor with per fusion prese rvation
  • 批准号:
    12671176
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $1.92万
  • 财政年份:
    2000
  • 负责人:
    NAGAO Takeshi
  • 依托单位:
Basic Study in Auxiliary Liver Transplantation Aiming for Clinical Trial
  • 批准号:
    09671256
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.3万
  • 财政年份:
    1997
  • 负责人:
    NAGAO Takeshi
  • 依托单位:
Auxiliary Liver Transplantation in Beagles
  • 批准号:
    07671291
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $1.34万
  • 财政年份:
    1995
  • 负责人:
    NAGAO Takeshi
  • 依托单位:
Xenograft in Large Animals
  • 批准号:
    03670579
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 资助金额:
    $1.28万
  • 财政年份:
    1991
  • 负责人:
    NAGAO Takeshi
  • 依托单位:
国内基金
海外基金
天然化合物引起的CYP3A4活性抑制和CYP3A4遗传活性变异对伏美替尼代谢的影响及机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    叶志泽
  • 依托单位:
CYP3A4活性变异重塑齐拉西酮的代谢特征及其分子机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    吴亚梦
  • 依托单位:
鼠李糖乳杆菌通过ILA/PXR/CYP3A4轴缓解雷公藤肝损伤的机制研究
HNF1A-AS1促进PXR相分离增强CYP3A4表达调控药物性肝损伤的分子机制研究
  • 批准号:
    82373947
  • 项目类别:
    面上项目
  • 资助金额:
    49万元
  • 批准年份:
    2023
  • 负责人:
    张莉蓉
  • 依托单位: